February 3, 2015 / 10:40 PM / 3 years ago

BUZZ-Myriad Genetics Inc: Cuts revenue, profit forecast for full year

** Molecular diagnostic’s shares down 16 pct at $31.78 in extended trading

** Company cuts revenue forecast to $730 mln-$740 mln for year ending June 30 from $800-$820 mln; adjusted profit/shr forecast to $1.50-$1.55 from $1.75-$1.85

** Says cut due to lag in getting reimbursement coverage for diagnostic services and increase in work-in-process

** CEO Peter Meldrum leaves company; To be suceeded by Mark Capone

** Stock gained 62 pct in 2014

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below